New RSV prevention program shows promise in cutting child hospitalizations
NCT ID NCT07164430
Summary
This study looked at whether new RSV prevention medicines given to babies and pregnant mothers reduced RSV-related hospital visits in children under 2 years old. Researchers analyzed health records from 2,792 children in the Australian Capital Territory, comparing hospital visits before and after the prevention program started in 2025. The goal was to understand how effective these new prevention options are at keeping young children out of the hospital with RSV.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for RESPIRATORY SYNCYTIAL VIRUS HOSPITALIZATIONS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The Canberra Hospital
Garran, Australian Capital Territory, 2605, Australia
Conditions
Explore the condition pages connected to this study.